tiprankstipranks
Advertisement
Advertisement

HK:2616 Stock Latest News

CStone Pharmaceuticals Raises Over HK$1 Billion in Completed Share Placement
Company AnnouncementsCStone Pharmaceuticals Raises Over HK$1 Billion in Completed Share Placement
6d ago
2616
CStone to Showcase Promising CS2009 Cancer Data Ahead of Global Phase III Push
PremiumCompany Announcements
CStone to Showcase Promising CS2009 Cancer Data Ahead of Global Phase III Push
6d ago
2616
CStone Showcases Three Novel ADC Candidates, Highlighting EGFR/HER3 Bispecific CS5007
PremiumCompany Announcements
CStone Showcases Three Novel ADC Candidates, Highlighting EGFR/HER3 Bispecific CS5007
8d ago
2616
CStone Pharmaceuticals to Raise About HK$1.05 Billion via Discounted Share Placement
PremiumCompany Announcements
CStone Pharmaceuticals to Raise About HK$1.05 Billion via Discounted Share Placement
13d ago
2616
CStone’s 2025 Loss Widens as R&D Spend Climbs Ahead of Pralsetinib NRDL Boost
PremiumCompany Announcements
CStone’s 2025 Loss Widens as R&D Spend Climbs Ahead of Pralsetinib NRDL Boost
1M ago
2616
CStone Fast-Tracks Global Phase III Plan After Strong Early Data for Trispecific Cancer Antibody CS2009
PremiumCompany AnnouncementsCStone Fast-Tracks Global Phase III Plan After Strong Early Data for Trispecific Cancer Antibody CS2009
1M ago
2616
CStone’s Sugemalimab Wins Top ESMO Backing for Stage III Lung Cancer
Premium
Company Announcements
CStone’s Sugemalimab Wins Top ESMO Backing for Stage III Lung Cancer
1M ago
2616
CStone to Showcase Three ADC Pipeline Programs at 2026 AACR Meeting
Premium
Company Announcements
CStone to Showcase Three ADC Pipeline Programs at 2026 AACR Meeting
1M ago
2616
CStone Wins Second UK Approval for Lung Cancer Drug Sugemalimab
PremiumCompany Announcements
CStone Wins Second UK Approval for Lung Cancer Drug Sugemalimab
2M ago
2616
CStone Wins U.S. FDA Green Light for Phase II Trial of Trispecific Cancer Antibody CS2009
PremiumCompany Announcements
CStone Wins U.S. FDA Green Light for Phase II Trial of Trispecific Cancer Antibody CS2009
2M ago
2616
CStone Pharmaceuticals Streamlines Company Secretary and Authorized Representative Roles
PremiumCompany Announcements
CStone Pharmaceuticals Streamlines Company Secretary and Authorized Representative Roles
3M ago
2616
CStone Pharmaceuticals Sets March Board Meeting and Investor Call to Detail 2025 Results and Oncology Pipeline Progress
PremiumCompany Announcements
CStone Pharmaceuticals Sets March Board Meeting and Investor Call to Detail 2025 Results and Oncology Pipeline Progress
3M ago
2616
CStone CEO Boosts Stake to 4.87% in Sign of Long-Term Confidence
PremiumCompany AnnouncementsCStone CEO Boosts Stake to 4.87% in Sign of Long-Term Confidence
3M ago
2616
CStone Pharmaceuticals Grants New Share Options and RSUs, Seeks Shareholder Nod for Director Awards
Premium
Company Announcements
CStone Pharmaceuticals Grants New Share Options and RSUs, Seeks Shareholder Nod for Director Awards
3M ago
2616
CStone Pharmaceuticals Reshapes Board With New Independent Director Appointment
Premium
Company Announcements
CStone Pharmaceuticals Reshapes Board With New Independent Director Appointment
3M ago
2616
CStone Pharmaceuticals Sets Out Board and Committee Structure
PremiumCompany Announcements
CStone Pharmaceuticals Sets Out Board and Committee Structure
3M ago
2616
CStone Pharmaceuticals’ GAVRETO® Gains Inclusion in China’s National Reimbursement Drug List
PremiumCompany Announcements
CStone Pharmaceuticals’ GAVRETO® Gains Inclusion in China’s National Reimbursement Drug List
5M ago
2616
CStone’s Sugemalimab Gains European Approval for Broader NSCLC Treatment
PremiumCompany Announcements
CStone’s Sugemalimab Gains European Approval for Broader NSCLC Treatment
5M ago
2616
CStone Pharmaceuticals Unveils CS2015 at ACAAI 2025
PremiumCompany Announcements
CStone Pharmaceuticals Unveils CS2015 at ACAAI 2025
6M ago
2616
CStone Pharmaceuticals Advances CS2009 Clinical Trials with NMPA Approval
PremiumCompany AnnouncementsCStone Pharmaceuticals Advances CS2009 Clinical Trials with NMPA Approval
6M ago
2616
CStone Pharmaceuticals Announces Board Composition and Roles
Premium
Company Announcements
CStone Pharmaceuticals Announces Board Composition and Roles
6M ago
2616
CStone Pharmaceuticals Announces Board Changes with New Appointment
Premium
Company Announcements
CStone Pharmaceuticals Announces Board Changes with New Appointment
6M ago
2616

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >